Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]The logo of French drugmaker Sanofi is seen in Paris, France, January 9, 2026. REUTERS/Gonzalo Fuentes/File Photo [Purchase Licensing Rights, opens new tab]March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical [(1177.HK), opens new tab] said on Wednesday its unit has signed an exclusive global licensing ...